For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251031:nRSe7722Fa&default-theme=true
RNS Number : 7722F SW (Finance) I PLC 31 October 2025
ANNOUNCEMENT OF THE SATISFACTION OF THE TRANSACTION EFFECTIVENESS CONDITIONS
SW (FINANCE) I PLC
Released 31 October 2025
SW (Finance) I PLC
31 October 2025
On 10 October 2025, SWS Holdings Limited (the "Scheme Company") announced in
connection with the proposed scheme of arrangement under Part 26 of the
Companies Act 2006 (the "Scheme") between the Scheme Company and each creditor
under the Scheme (the "Scheme Creditors"), the occurrence of the Scheme
Effective Date, following the delivery of an office copy of the sealed
Sanction Order to the Registrar of Companies for registration of the Scheme.
Pursuant to the Scheme, the Scheme CTA Amendment Agreement was entered into by
the Scheme Company, SWS and the Security Trustee on 13 October 2025.
Notice is hereby given of the satisfaction of each of the Transaction
Effectiveness Conditions, pursuant to which SWS can confirm that it has
submitted the First OpCo Funding Request to the Sponsor Entity in connection
with the contribution of the Initial Equity Injection.
As a result, the Initial Equity Injection will be made available and
contributed in full in the amount of £505,000,000 to SWS in accordance with
the terms of the Equity Commitment Letter and in accordance with the First
OpCo Funding Request by 28 November 2025, upon which the Transaction Effective
Date will automatically occur.
The Scheme forms part of the group's broader recapitalisation to, amongst
other things, receive equity support led by funds managed by Macquarie Asset
Management to help fund its 2025-30 investment programme. This comprises a
legally binding equity commitment of £655 million, provided on the terms of
an equity commitment letter, and a confirmation of intent to provide further
equity commitments of up to an additional £545 million, with a minimum of
£245 million, by December 2025.
Capitalised terms used but not defined in this announcement shall have the
meaning given to them in the Scheme.
For further information, please contact Stuart Ledger (Group CFO) at:
Address: Southern House, Yeoman Road, Worthing, BN13 3NX,
United Kingdom
Tel: 01903 272 611
Email: stuart.ledger@southernwater.co.uk
DISCLAIMER - INTENDED ADDRESSEES
This announcement is a communication to the market. Nothing in this
announcement constitutes an offer of securities for sale in the United States
or any other jurisdiction. This announcement does not constitute a prospectus
or a prospectus equivalent document.
This announcement has been delivered to you on the basis that you are a person
into whose possession this announcement may be lawfully delivered in
accordance with the laws of the jurisdiction in which you are located and you
may not, nor are you authorised to, deliver this announcement to any other
person. The distribution of this announcement in jurisdictions other than the
United Kingdom may be restricted by law and therefore persons into whose
possession this announcement comes should inform themselves about, and
observe, such restrictions. Any failure to comply with the restrictions may
constitute a violation of the securities laws of any such jurisdiction.
Your right to access this service is conditional upon complying with the above
requirement.
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END SOABRBDGDBXDGUB
Copyright 2019 Regulatory News Service, all rights reserved